F. Xie

发表

Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination.

S. Block, P. Dull, P. Keshavan, 2015, Vaccine.

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)

G. Zuccotti, D. Toneatto, S. Esposito, 2014, Human vaccines & immunotherapeutics.

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.

K. Reisinger, D. Parenti, Y. Baine, 2001, Vaccine.

A phase II randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)

G. Zuccotti, D. Toneatto, S. Esposito, 2014, Human vaccines & immunotherapeutics.

Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label Trial

S. Block, P. Dull, H. Garfield, 2016, The Pediatric infectious disease journal.

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study

Kui-cheng Zheng, F. Xie, Dongjuan Zhang, 2022, Vaccines.

Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: A randomized open-label study

Rong-cheng Li, Yan-ping Li, Y. Nong, 2015, Human vaccines & immunotherapeutics.

Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.

F. Xie, J. Beran, M. Lattanzi, 2018, Vaccine.

Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.

F. Xie, J. Beran, O. Zent, 2014, Vaccine.

Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.

G. Shao, Haidong Xie, Chunlai Wang, 2014, Vaccine.

Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.

R. Janssen, D. Shemin, M. Girndt, 2023, Vaccine.

An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With a Haemophilus influenzaeType b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants

Chin‐Yun Lee, Li-Min Huang, P. Lee, 1999, Pediatrics.